TPG Specialty Lending Earnings Calls
| Release date | May 05, 2026 |
| EPS estimate | $0.490 |
| EPS actual | $0.420 |
| EPS Surprise | -14.29% |
| Revenue estimate | 103.14M |
| Revenue actual | 93.4M |
| Revenue Surprise | -9.44% |
| Release date | Feb 12, 2026 |
| EPS estimate | $0.500 |
| EPS actual | $0.520 |
| EPS Surprise | 4.00% |
| Revenue estimate | 104.371M |
| Revenue actual | 108.2M |
| Revenue Surprise | 3.67% |
| Release date | Nov 04, 2025 |
| EPS estimate | $0.520 |
| EPS actual | $0.530 |
| EPS Surprise | 1.92% |
| Revenue estimate | 107.109M |
| Revenue actual | 81.142M |
| Revenue Surprise | -24.24% |
| Release date | Jul 30, 2025 |
| EPS estimate | $0.530 |
| EPS actual | $0.560 |
| EPS Surprise | 5.66% |
| Revenue estimate | 108.349M |
| Revenue actual | 112.463M |
| Revenue Surprise | 3.80% |
Last 4 Quarters for TPG Specialty Lending
Below you can see how TSLX performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jul 30, 2025 |
| Price on release | $23.66 |
| EPS estimate | $0.530 |
| EPS actual | $0.560 |
| EPS surprise | 5.66% |
| Date | Price |
|---|---|
| Jul 24, 2025 | $24.40 |
| Jul 25, 2025 | $24.45 |
| Jul 28, 2025 | $23.99 |
| Jul 29, 2025 | $23.87 |
| Jul 30, 2025 | $23.66 |
| Jul 31, 2025 | $24.28 |
| Aug 01, 2025 | $23.91 |
| Aug 04, 2025 | $23.79 |
| Aug 05, 2025 | $23.75 |
| 4 days before | -3.03% |
| 4 days after | 0.380% |
| On release day | 2.62% |
| Change in period | -2.66% |
| Release date | Nov 04, 2025 |
| Price on release | $22.32 |
| EPS estimate | $0.520 |
| EPS actual | $0.530 |
| EPS surprise | 1.92% |
| Date | Price |
|---|---|
| Oct 29, 2025 | $22.78 |
| Oct 30, 2025 | $22.57 |
| Oct 31, 2025 | $22.62 |
| Nov 03, 2025 | $22.64 |
| Nov 04, 2025 | $22.32 |
| Nov 05, 2025 | $21.85 |
| Nov 06, 2025 | $21.17 |
| Nov 07, 2025 | $21.19 |
| Nov 10, 2025 | $21.00 |
| 4 days before | -2.02% |
| 4 days after | -5.91% |
| On release day | -2.11% |
| Change in period | -7.81% |
| Release date | Feb 12, 2026 |
| Price on release | $20.12 |
| EPS estimate | $0.500 |
| EPS actual | $0.520 |
| EPS surprise | 4.00% |
| Date | Price |
|---|---|
| Feb 06, 2026 | $20.17 |
| Feb 09, 2026 | $19.95 |
| Feb 10, 2026 | $20.28 |
| Feb 11, 2026 | $20.11 |
| Feb 12, 2026 | $20.12 |
| Feb 13, 2026 | $19.23 |
| Feb 17, 2026 | $18.88 |
| Feb 18, 2026 | $19.25 |
| Feb 19, 2026 | $18.68 |
| 4 days before | -0.248% |
| 4 days after | -7.16% |
| On release day | -4.42% |
| Change in period | -7.39% |
| Release date | May 05, 2026 |
| Price on release | $19.60 |
| EPS estimate | $0.490 |
| EPS actual | $0.420 |
| EPS surprise | -14.29% |
| Date | Price |
|---|---|
| Apr 29, 2026 | $18.94 |
| Apr 30, 2026 | $19.60 |
| May 01, 2026 | $19.65 |
| May 04, 2026 | $19.76 |
| May 05, 2026 | $19.60 |
| May 06, 2026 | $17.91 |
| May 07, 2026 | $17.88 |
| May 08, 2026 | $17.94 |
| May 11, 2026 | $17.40 |
| 4 days before | 3.48% |
| 4 days after | -11.22% |
| On release day | -8.62% |
| Change in period | -8.13% |
TPG Specialty Lending Earnings Call Transcript Summary of Q1 2026
Sixth Street Specialty Lending (SLX) reported Q1 2026 net investment income of $0.42 per share and a net loss per share of $0.27 due primarily to unrealized fair value marks driven by wider market credit spreads and lower market multiples. NAV declined to $16.24 per share (a ~4.3% decline from $16.97), with approximately $0.58 per share of that decline attributable to market-driven fair value movements (about $0.40 from debt spread widening and $0.18 from equity valuation changes). Management emphasized these are largely noncash, market-driven marks that they expect to reverse over time as markets normalize and investments mature. Activity-based fee income was muted in the quarter ($0.05 per share) versus its longer-term average, prompting the Board to lower the base quarterly dividend from $0.46 to $0.42 (annualized yield ~10.3% on March 31 NAV) to align distributions with near-term forward earnings visibility while preserving the supplemental dividend framework to capture upside if activity recovers. Portfolio fundamentals were described as healthy: $3.3 billion of total investments, $1.8 billion of principal debt outstanding, net assets $1.5 billion, weighted average yield on debt ~11.2% at amortized cost, conservative attachment/detachment leverage (0.4x / 5.2x), weighted interest coverage 2.3x, and low nonaccruals (3 names, ~1.4% of portfolio at fair value). Q1 activity included $338M of commitments and $135M of fundings (new investments and upsizes), $113M of repayments, and select successful realizations (e.g., Galileo Parent and MadCap with strong asset-level IRRs). Liquidity and balance sheet strength were highlighted: $1.1B unfunded revolver capacity at quarter end (later enhanced by a revolver extension to May 2031 with all 19 banks participating), resulting pro forma liquidity of $649M after accounting for near-term notes. Management reiterated long-term track record of NAV outperformance since IPO, commitment to disciplined underwriting, and readiness to deploy capital into higher-spread opportunities emerging from market dislocation. Guidance: if portfolio turnover remains below 20% for the year, ROE is expected ~10%–10.5%; higher turnover would push ROE above 10.5%.
Sign In
Buy TSLX